Fluxus, Inc.
Robert Feldman is currently serving as an Advisor at Silicon Catalyst, a semiconductor-focused incubator and accelerator. Robert also holds the position of Senior Vice President at Fluxus Inc., a biochip-based diagnostics company. Additionally, Robert is a member of the Board of Directors at RealSeq Biosciences, a Strategic Advisor at S2 Genomics, and previously served as President and CEO of Prime Genomics. With a background in genetics and biology, Robert has a wealth of experience in the life sciences industry, from business development to strategic advising.
Fluxus, Inc.
Fluxus Inc. is a privately held development-stage medical device company located in Sunnyvale, CA, USA. The Company’s immediate focus is the development and commercialization of biochip-based detection platforms for ultra-high sensitivity diagnostics and bioanalytical applications. Our culture represents innovative, driven, and talented professionals with diverse perspectives, but one which is united on a mission to significantly and positively make a difference in healthcare.